international immunopharmacology

Frontiers in immunology

[1] plasma cytokine response, lipid peroxidation and nf-κb activation in skeletal muscle following maximum progressive swimming

[2] roles of elevated intravitreal il-1β and il-10 levels in proliferative diabetic retinopathy

[3] impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia

[4] costimulatory molecules on immunogenic versus tolerogenic human dendritic cells

[5] recurrence and massive extraocular extension of choroidal malignant melanoma after vitrectomy and endoresection

[6] the limited immunomodulatory effects of escharectomy on the kinetics of endotoxin, cytokines, and adhesion molecules in major burns

[7] etiology and cytokine expression in patients requiring mechanical ventilation due to severe community-acquired pneumonia

[8] infusion of human umbilical cord blood cells ameliorates hind limb dysfunction in experimental spinal cord injury through anti-inflammatory, vasculogenic and neurotrophic mechanisms

[9] plasma transforming growth factor-β1 level in patients with severe community-acquired pneumonia and association with disease severity

[10] il-10 dysregulation in acute mountain sickness revealed by transcriptome analysis

[11] induction of interleukin-10 producing dendritic cells as a tool to suppress allergen-specific t helper 2 responses

[12] Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze

[13] Effect of scaling and root planing on serum interleukin-10 levels and glycemic control in chronic periodontitis and type 2 diabetes mellitus

[14] 14BME20 Prevents Allergic Airway Inflammation by Induction of Regulatory T Cells via Interleukin-10.

[15] [Association of interleukin-10 gene polymorphism with enterovirus 71 infection in children].

[16] Involvement of Interleukin-10 in Analgesia of Electroacupuncture on Incision Pain.

[17] Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.

[18] Determinants of Response to Interleukin-10 Receptor Blockade Immunotherapy in Experimental Visceral Leishmaniasis

[19] Recent insights into microbial triggers of interleukin-10 production in the host and the impact on infectious disease pathogenesis

[20] Koi Herpesvirus Encodes and Expresses a Functional Interleukin-10

[21] impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia

[22] potential use of interleukin-10 blockade as a therapeutic strategy in human cutaneous leishmaniasis

[23] polymorphisms in the interleukin-10 gene and chronic periodontitis in patients with atherosclerotic and aortic aneurysmal vascular diseases

[24] bee venom acupuncture reduces interleukin-6, increases interleukin-10, and induces locomotor recovery in a model of spinal cord compression

[25] molecular characterization of the onset and progression of colitis in inoculated interleukin-10 gene-deficient mice: a role for pparα

[26] increased production of interleukin-4, interleukin-10, and granulocyte-macrophage colony-stimulating factor by type 2 diabetes’ mononuclear cells infected with dengue virus, but not increased intracellular viral multiplication

[27] significant roles played by interleukin-10 in outcome of pregnancy

[28] schistosoma mansoni antigen-driven interleukin-10 production in infected asthmatic individuals

[29] induction of interleukin-10 producing dendritic cells as a tool to suppress allergen-specific t helper 2 responses

[30] USE OF A THRESHOLD OF INTERLEUKIN-10 AND IL-10/IL-6 RATIO IN OCULAR SAMPLES FOR THE SCREENING OF VITREORETINAL LYMPHOMA

[31] Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection